Antimicrobial resistance represents a serious threat for global health, causing an unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in 2017, carbapenem-resistant organisms were listed by the WHO among the group of pathogens for which novel treatment strategies are urgently needed. Fortunately, several drugs and combinations have been introduced in recent years to treat multi-drug-resistant (MDR) bacteria. However, a correct use of these molecules is needed to preserve their efficacy. In the present paper, we will provide an overview on the epidemiology and mechanisms of resistance of the most common MDR Gram-negative bacteria, proposing a treatment algorithm for the management of infections due to carbapenem-resistant bacteria based on the most recent clinical evidence.
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion / Coppola, N.; Maraolo, A. E.; Onorato, L.; Scotto, R.; Calo, F.; Atripaldi, L.; Borrelli, A.; Corcione, A.; De Cristofaro, M. G.; Durante-Mangoni, E.; Filippelli, A.; Franci, G.; Galdo, M.; Guglielmi, G.; Pagliano, P.; Perrella, A.; Piazza, O.; Picardi, M.; Punzi, R.; Trama, U.; Gentile, I.. - In: ANTIBIOTICS. - ISSN 2079-6382. - 11:9(2022). [10.3390/antibiotics11091263]
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion
Maraolo A. E.Secondo
Conceptualization
;Onorato L.;Scotto R.;Atripaldi L.;Franci G.;Galdo M.;Piazza O.;Picardi M.;Trama U.;Gentile I.
2022
Abstract
Antimicrobial resistance represents a serious threat for global health, causing an unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in 2017, carbapenem-resistant organisms were listed by the WHO among the group of pathogens for which novel treatment strategies are urgently needed. Fortunately, several drugs and combinations have been introduced in recent years to treat multi-drug-resistant (MDR) bacteria. However, a correct use of these molecules is needed to preserve their efficacy. In the present paper, we will provide an overview on the epidemiology and mechanisms of resistance of the most common MDR Gram-negative bacteria, proposing a treatment algorithm for the management of infections due to carbapenem-resistant bacteria based on the most recent clinical evidence.| File | Dimensione | Formato | |
|---|---|---|---|
|
antibiotics-11-01263-v2.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
634.3 kB
Formato
Adobe PDF
|
634.3 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
